These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 22248266)

  • 1. In silico models for drug-induced liver injury--current status.
    Przybylak KR; Cronin MT
    Expert Opin Drug Metab Toxicol; 2012 Feb; 8(2):201-17. PubMed ID: 22248266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristic molecular and proteomic signatures of drug-induced liver injury in a rat model.
    Eun JW; Bae HJ; Shen Q; Park SJ; Kim HS; Shin WC; Yang HD; Jin CY; You JS; Kang HJ; Kim H; Ahn YM; Park WS; Lee JY; Nam SW
    J Appl Toxicol; 2015 Feb; 35(2):152-64. PubMed ID: 25231249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative structure-activity relationship models for predicting drug-induced liver injury based on FDA-approved drug labeling annotation and using a large collection of drugs.
    Chen M; Hong H; Fang H; Kelly R; Zhou G; Borlak J; Tong W
    Toxicol Sci; 2013 Nov; 136(1):242-9. PubMed ID: 23997115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hybrid in silico models for drug-induced liver injury using chemical descriptors and in vitro cell-imaging information.
    Zhu XW; Sedykh A; Liu SS
    J Appl Toxicol; 2014 Mar; 34(3):281-8. PubMed ID: 23640866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current challenges and controversies in drug-induced liver injury.
    Corsini A; Ganey P; Ju C; Kaplowitz N; Pessayre D; Roth R; Watkins PB; Albassam M; Liu B; Stancic S; Suter L; Bortolini M
    Drug Saf; 2012 Dec; 35(12):1099-117. PubMed ID: 23137150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In-silico approach for drug induced liver injury prediction: Recent advances.
    Saini N; Bakshi S; Sharma S
    Toxicol Lett; 2018 Oct; 295():288-295. PubMed ID: 29981923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is toxicogenomics a more reliable and sensitive biomarker than conventional indicators from rats to predict drug-induced liver injury in humans?
    Zhang M; Chen M; Tong W
    Chem Res Toxicol; 2012 Jan; 25(1):122-9. PubMed ID: 22122743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toward predictive models for drug-induced liver injury in humans: are we there yet?
    Chen M; Bisgin H; Tong L; Hong H; Fang H; Borlak J; Tong W
    Biomark Med; 2014; 8(2):201-13. PubMed ID: 24521015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predicting and preventing acute drug-induced liver injury: what's new in 2010?
    Liss G; Rattan S; Lewis JH
    Expert Opin Drug Metab Toxicol; 2010 Sep; 6(9):1047-61. PubMed ID: 20615079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug-induced liver injury: a summary of recent advances.
    Stine JG; Lewis JH
    Expert Opin Drug Metab Toxicol; 2011 Jul; 7(7):875-90. PubMed ID: 21510822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Highlights of drug - and herb- induced liver injury in the literature from 2016: how best to translate new information into clinical practice?
    Shahbaz O; Mahajan S; Lewis JH
    Expert Opin Drug Metab Toxicol; 2017 Sep; 13(9):935-951. PubMed ID: 28772086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advancing Predictive Hepatotoxicity at the Intersection of Experimental, in Silico, and Artificial Intelligence Technologies.
    Fraser K; Bruckner DM; Dordick JS
    Chem Res Toxicol; 2018 Jun; 31(6):412-430. PubMed ID: 29722533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In Silico Prediction of Drug-Induced Liver Injury Based on Adverse Drug Reaction Reports.
    Zhu XW; Li SJ
    Toxicol Sci; 2017 Aug; 158(2):391-400. PubMed ID: 28521054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Idiosyncratic drug-induced liver injury: an update on the 2007 overview.
    Hussaini SH; Farrington EA
    Expert Opin Drug Saf; 2014 Jan; 13(1):67-81. PubMed ID: 24073714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A high content screening assay to predict human drug-induced liver injury during drug discovery.
    Persson M; Løye AF; Mow T; Hornberg JJ
    J Pharmacol Toxicol Methods; 2013; 68(3):302-13. PubMed ID: 23933113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug-induced liver injury: a safety review.
    García-Cortés M; Ortega-Alonso A; Lucena MI; Andrade RJ;
    Expert Opin Drug Saf; 2018 Aug; 17(8):795-804. PubMed ID: 30059261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An In Silico Model for Predicting Drug-Induced Hepatotoxicity.
    He S; Ye T; Wang R; Zhang C; Zhang X; Sun G; Sun X
    Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 30999595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of novel tools for the in vitro investigation of drug-induced liver injury.
    Jiang J; Wolters JE; van Breda SG; Kleinjans JC; de Kok TM
    Expert Opin Drug Metab Toxicol; 2015; 11(10):1523-37. PubMed ID: 26155718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug-induced liver injury: what was new in 2013?
    Chalhoub WM; Sliman KD; Arumuganathan M; Lewis JH
    Expert Opin Drug Metab Toxicol; 2014 Jul; 10(7):959-80. PubMed ID: 24746272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug-induced liver injury and drug development: industry perspective.
    Regev A
    Semin Liver Dis; 2014 May; 34(2):227-39. PubMed ID: 24879986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.